Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03593356 · ClinicalTrials.gov registry record · NA

Baby's First Years

A NA study of Child Development and Brain Development, sponsored by University of California, Irvine.

Active
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT03593356: Active NA study of Child Development and Brain Development, sponsored by University of California, Irvine.

NCT03593356 is a NA study of Child Development and Brain Development that is active but no longer recruiting, run by University of California, Irvine. The registered enrollment target is 1,000 participants, roughly in line with the 1,062-participant average among 32 other Child Development trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03593356, a NA study of Child Development and Brain Development, is active but no longer recruiting, sponsored by University of California, Irvine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

Recent advances in developmental neuroscience suggest that experiences early in life can have profound and enduring influences on the developing brain. Family economic resources shape the nature of many of these experiences, yet the extent to which they affect children's development is unknown. The project's team of neuroscientists, economists and developmental psychologists is seeking to fill important gaps in scientific knowledge about the role of economic resources in early development by evaluating the first U.S. randomized controlled trial to determine whether unconditional cash gift payments have a causal effect on the cognitive, socio-emotional and brain development of infants and toddlers in low-income U.S. families. Specifically, 1,000 mothers of infants with incomes below the federal poverty line from four diverse U.S. communities were recruited from post-partum wards and are receiving monthly cash gift payments by debit card for the first 76 months of the child's life. Parents in the experimental group and receiving $333 per month ($3,996 per year), whereas parents in the active comparator group are receiving a nominal monthly payment of $20. In order to understand the impacts of the added income on children's cognitive and behavioral development, the investigators are assessing treatment group differences at ages 4 (this lab assessment was postponed from age 3 to age 4 due to Covid-19), 6, and 8 in lab-administered measures of cognitive, language, and self-regulation development and maternal reports of socio-emotional development. A number of other maternal-reported child outcome measures were gathered at ages 1, 2 and 3. Brain circuitry may be sensitive to the effects of early experience even before early behavioral differences can be detected. In order to understand the impacts of added income on children's brain functioning at age 4, 6, and 8, the investigators will assess, during a lab visit, experimental/active comparator group differences in measu

Primary Outcome

Measured by Receptive One Word Picture Vocabulary Test (ROWPVT). We analyze conceptual vocabulary scores. Minimum raw value: 0; Maximum raw value: 111. Higher score indicates a better outcome. References: Martin, N. A., \& Brownell, R. (2011). ROWPVT-4: Receptive One-Word Picture Vocabulary Test.

Interventions

  • BEHAVIORAL Monthly cash gift payments of $333
  • BEHAVIORAL Monthly cash gift payments of $20

Study Locations (1)

New York

  • 12 hospitals in the following four metropolitan areas: New York, Omaha, New Orleans, and Twin Cities - New York

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2018-05-09
Est. Completion 2028-08-31
Phase NA
University of California, Irvine

368 total trials

What the registry record for NCT03593356 still lists

NCT03593356 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,062-participant average among 32 other Child Development trials with a reported enrollment target.

The record links to 3 conditions, with Child Development appearing as the primary indexed condition, and to 2 interventions - of which Monthly cash gift payments of $333 is the first listed.

NCT03593356 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03593356 about?

NCT03593356 is a clinical study titled "Baby's First Years". Recent advances in developmental neuroscience suggest that experiences early in life can have profound and enduring influences on the developing brain. Family economic resources shape the nature of many of these experiences, yet the extent to which they affect children's development is unknown. The ...

What is the current status of trial NCT03593356?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2018-05-09. Estimated completion is 2028-08-31.

What conditions does trial NCT03593356 study?

This clinical trial studies the following conditions: Child Development, Brain Development, Household and Family Processes.

What interventions are being tested in trial NCT03593356?

The interventions under investigation include: Monthly cash gift payments of $333 (BEHAVIORAL), Monthly cash gift payments of $20 (BEHAVIORAL).

Who is sponsoring clinical trial NCT03593356?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03593356 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Child Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03593356's enrollment target sits among peer trials

1,000 4th of 32 higher than 28 of 32 other Child Development trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Child Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03593356, the US trial registry maintained by the National Library of Medicine. NCT03593356 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.